FIRRM and lung cancer: Compared with the normal tissues (p < 0.01, |log2 fold change| >1.5), we found that C1ORF112 was upregulated in almost all cancer types (Figure 1A), including colorectal cancer, breast cancer, lung cancer, sarcomas, and tumors of the CNS.